INTRODUCTION
The hydrolysis of PtdIns(4,5)P 2 by PI-PLC (phosphoinositidespecific phospholipase C) occurs in response to a large number of extracellular signals (reviewed in [1] [2] [3] ). Four families of mammalian PI-PLC, PLCβ (β1-β4), PLCγ (γ 1 and γ 2), PLCδ (δ1-δ4) and PLCε, have been described. Each family is characterized by the distinct domain organization and type of signalling pathways that regulate enzyme activity.
PLCγ isoforms are mainly regulated through receptors with intrinsic tyrosine kinase activity (e.g. growth factor receptors) or receptors [such as BCR and TCR (B-and T-cell antigen receptors respectively)] that are linked to the activation of nonreceptor tyrosine kinases through a complex signalling network [1] [2] [3] [4] . Regulation of PLCγ 1 by growth factor receptors, where the receptor provides the main membrane-binding partner and the tyrosine kinase acting on PLCγ , has been studied extensively. The extent to which production of PtdIns(3,4,5)P 3 also contributes to stimulation of PLCγ 1 by the tyrosine kinase receptors varies depending on the cell system and the type of receptor [5] [6] [7] . Other signalling components may also be involved in regulation of growth-factor-triggered PLCγ 1 activity; for example, recent data have implied that c-Cbl has a direct interaction with PLCγ 1 [8] . Studies of PLCγ isoforms in haematopoietic cells, in particular PLCγ 1 signalling in response to the cross-linking of TCR and PLCγ 2 signalling following stimulation of BCR, revealed
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some general similarities in the type of components required for regulation of PLC activity in these more complex systems [9] [10] [11] . The involvement of non-receptor protein tyrosine kinases, such as Src, Syk/Zap70 and Tec families, cell-type specific adapter proteins, PI3K (phosphoinositide 3-kinase) and members of Cbl family, is either critical or plays a role in regulation of intensity and duration of PtdIns(4,5)P 2 hydrolysis. Based on studies in DT40 cells and several other B-cell lines, the signalling components in B-cells involved in regulation of PLCγ 2 include the tyrosine kinases Lyn, Syk and Btk, PI3K and an adapter protein BLNK (B-cell linker); it has been suggested that BLNK provides a direct interacting partner and that Btk could be directly involved in phosphorylation of critical tyrosine residues in PLCγ 2 [10, 11] .
A further level of complexity in regulation of PLCγ isoforms may be provided by specific membrane targeting to the lipid rafts, also known as glycolipid-enriched microdomains. There is evidence suggesting the importance of the integrity of these specific microdomains in EGF (epidermal growth factor) receptor stimulation of PLCγ 1 [12] . However, the function of lipid rafts have been more extensively studied in B-and T-cells [9, 13] , with the data generally supporting formation of BCR-and TCRsignalling complexes in this structure, which may also regulate cross-talk between different receptors (e.g. BCR and CD19 in B-cells). Although several reports suggest that the presence of raft structures in the plasma membrane seem to be required for PLCγ -mediated signalling [14, 15] , this signalling may not be confined to the rafts and, in the case of signalling by BCR crosslinking, the raft targeting could be dependent on the stage in B-cell development [16, 17] .
In contrast with extensive information regarding signalling networks involved in the regulation of PLCγ isoforms by receptor and non-receptor tyrosine kinases, the precise mechanism of transition from an inactive to active form of PLCγ remains unclear. Nevertheless, one requirement that has been defined in both systems is translocation of PLCγ isoforms to the plasma membrane. Studies in growth-factor-stimulated cells demonstrated the role of the SH2 (Src homology 2) domains of PLCγ as a driving force for the translocation to the plasma membrane, which is mediated by direct interaction with the receptor [12, 18] . Similarly, the requirements for the PLCγ 2 SH2 domains and interaction with BLNK have been shown in B-cells following BCR cross-linking [19] [20] [21] . Interestingly, the recruitment of PLCγ 1 to signalling complex in T-cells involves interactions with two adapter proteins [Slp-76 (SH2 domain containing leucocyte protein of 65 kDa) and Lat (linker for activation of T-cell)] and requires the SH2 and SH3 domains of PLCγ 1 [4] . There is also evidence that in some systems PI3K can indirectly or directly support translocation [5, 22] . While the translocation is clearly important, other changes, most notably phosphorylation of specific tyrosine residues, are involved in stimulation of PLCγ isoforms [23] [24] [25] . Other ways of stimulation of PLCγ that do not involve tyrosine phosphorylation have also been suggested [26] . There are several lines of experimental evidence (including limited proteolysis and peptide inhibition) suggesting that an intramolecular inhibitory constraint is imposed by regions within the PLCγ -specific domain array [γ SA, comprising the 'split' PH (pleckstrin homology) domain, two SH2 domains and one SH3 domain] [27] [28] [29] . Therefore, it could be speculated that phosphorylation of essential tyrosine residues in this region (e.g. Tyr 783 in PLCγ 1 and Tyr  753 and  Tyr  759 in PLCγ 2) and/or other interactions with the SH2 or SH3 domains could result in conformational changes that overcome this intramolecular inhibition. Another area where experimental evidence is lacking concerns the relationship between translocation and changes that could result in an increase of substrate hydrolysis, in particular, whether these could, at least in part, be mediated by the same interactions. Specifically, in B-cells signalling components, such as BLNK, could be involved in both translocation and activation of PLCγ 2. Similarly, some domains of PLCγ 2 (e.g. SH2 domains) could be involved in both processes.
In the present study we have described further insights into PLCγ 2 signalling in DT40 B-cell lines following either BCR cross-linking or exposure to H 2 O 2 , which are known to trigger similar signalling pathways [30] [31] [32] . Since it has been reported that PLCγ 2 signalling in B-cells could be either stimulated [14] or inhibited [33] by the formation of lipid-raft structures and that BCR signalling could also take place outside lipid rafts in immature B-cells [17] , it was important to directly examine the ability of different regions of the plasma membrane to sustain PLCγ 2 signalling. We have found that the raft targeting is essential for the BCR and also for stress-induced Ins(1,4,5)P 3 production in DT40 B-cell line.
When the localization to rafts was achieved using the targeting sequence from Src family kinase Lyn, the activation of Lyn-PLCγ 2 almost completely overcame the requirement for BLNK. This targeting, not accompanied by an increase in substrate hydrolysis, suggested that it represents a separate step from the stimulation of PLC activity, and therefore enabled further studies of the interactions specifically required for the activation of targeted PLCγ 2, which have been difficult to address in previous studies of PLCγ isoforms. While BLNK was clearly not required for the activation, we have found that this step, when triggered by the cross-linking of BCR, involves stimulation of Syk, Btk and PI3K; the requirement for these components was less stringent in H 2 O 2 -induced stress responses. We have also found that the PLCγ 2 SH2 domains did not have an important role in transient activation of the raft-targeted Lyn-PLCγ 2, which is in contrast with specific tyrosine residues (Tyr 753 and Tyr 759 ) that were essential for both BCR cross-linking and H 2 O 2 -induced responses.
EXPERIMENTAL

Constructs for expression in DT40 B-cells
For the expression of wild-type human PLCγ 2 in DT40 (chicken B-lymphoma) cell line, the full-length cDNA of PLCγ 2 was subcloned into the pApuro vector to generate the previously described pApuroPLCγ 2 construct [18] . The chimera PHδ1PLCγ 2, encoding amino acids 1-134 from rat PLCδ1 and residues 134-1265 from human PLCγ 2, was generated using the two-stage PCR-based extension method. The PCR fragment, encoding the N-terminal portion of the chimera, was subcloned into a vector generated by EcoRI cleavage of pAPuroPLCγ 2 to produce pAPuroPHδ1PLCγ 2 plasmid. The two-stage PCR approach was also used to generate construct incorporating 9 amino acids from the N-terminus of the Src kinase Lyn (G 2 CIKSKGKD 10 ) between the first and second amino acids residues of PLCγ 2. The PCR fragment incorporating this Lyntag was subcloned into pAPuroPLCγ 2, using unique EcoRI sites, generating pAPuroLyn-PLCγ 2. This PCR fragment was also subcloned into a plasmid encoding PLCγ 2 with mutations of two critical tyrosine residues, pAPuroPLCγ 2 Y753F/Y759F (where Y753F is the substitution Tyr 753 → Phe etc.) [24] , creating a Lyn-tag at the N-terminus of the construct (pAPuroLyn-PLCγ 2 Y753F/Y759F ). To generate pAPuroLyn-PLCγ 2 R564A/R672A , where mutations are introduced into the N-and C-terminal SH2 domains in the context of Lyn-PLCγ 2, the following strategy was used. First, pAPuroPLCγ 2 R564A/R672A was made by subcloning the entire coding region from pVL1393PLCγ 2 R564A/R672A (the mutations were generated as described in [18] ) into pAPuro, using KpnI and blunt-ended EcoRI restriction sites. The PCR fragment incorporating the Lyn-tag was subsequently subcloned into pAPuroPLCγ 2 R564A/R672A using the same strategy as described for pAPuroLyn-PLCγ 2. A fragment incorporating sequence of human BLNK was subcloned into pApuro from a previously described plasmid [24] , using KpnI and blunt-ended BamHI restriction sites.
Generation of stable D40 cell lines
DT40 cells (the wild-type and PLCγ 2-, BLNK-, Btk-and Sykdeficient) were maintained in RPMI 1640 medium, supplemented with 10 % (v/v) foetal bovine serum (Gibco), 1 % (v/v) chicken serum (Gibco) and 3 mM glutamine, in the presence of 5 % CO 2 at 40
• C. Stable transfectants of DT40 cells were generated as described previously [18, 24] . Briefly, various PLCγ 2 and BLNK constructs in pApuro were linearized and introduced into DT40 cell lines (PLCγ 2-, BLNK-, Syk-or Btk-deficient) by electroporation (950 V, 25 µF, ∞ ; Gene Pulser, Bio-Rad Laboratories). After 24 h, puromycin (0.35 µg/ml for PLCγ 2-deficient and 0.29 µg/ml for BLNK-, Syk-and Btk-deficient cells) was added to the medium. After the selection (10-12 days), colonies were isolated and puromycin (0.3 µg/ml) selection repeated for 5-8 days. Subsequently, the puromycin-resistant colonies were grown in normal medium for a further 6 days. Generated stable cell lines are listed in Table 1 . Intracellular Ca 2+ concentrations in DT40 cells were measured using fluorescence spectroscopy, essentially as described previously [18, 24] . Briefly, a cell suspension of 5 × 10 6 cells was loaded with 2 µM Fluo 3/AM (Fluo-3 acetoxymethyl ester) (Molecular Probes) in RPMI 1640 medium for 1 h at 20 • C for the time indicated in the Figure legends. The incubation was stopped with 50 µl of ice-cold 15 % (w/v) trichloroacetic acid. After centrifugation at 5000 rev./min for 15 min, the supernatants were washed four times with 1 ml of water-saturated diethyl-ether and used for Ins(1,4,5)P 3 mass measurements with the reagents supplied by the manufacturers.
For experiments using the PI3K inhibitors LY294002 (Calbiochem) and wortmannin (Calbiochem), DT40 cells were loaded with 2 µM Fluo 3/AM for 30 min at 40
• C (for Ca 2+ measurements only) and incubated with 50 µM LY294002 or 100 nM wortmannin for a further 30 min. Cells were then stimulated with 2 mM H 2 O 2 or 10 µg/ml M4. Intracellular Ca 2+ mobilization and Ins(1,4,5)P 3 production was measured as described above. Cell fractionation and preparation of the lipids rafts (glycolipidenriched membranes) was based on previously published methods [34, 35] . DT40 cells (3 × 10 7 ) were resuspended in 200 µl of lysis buffer (60 mM Tris/HCl, pH 8.0, 150 mM NaCl, 5 mM EDTA, 1 mM Na 3 VO 4 , protease and phosphatase inhibitors) without detergent, and sonicated three times with 5-s pulses. Samples were adjusted to a total volume of 1 ml in lysis buffer containing 1 % (w/v) Brij 58 (Sigma) and maintained on ice for 1 h. The lysates were then mixed with 85 % (w/v) sucrose in 60 mM Tris/HCl (pH 8.0), containing 150 mM NaCl and 5 mM EDTA (pH 8.0) and transferred to polyallomer centrifuge tubes (Beckman). A 2-ml volume of 30 % (w/v) sucrose was layered on top, followed by 1 ml of 5 % (w/v) sucrose. Samples were subjected to centrifugation in a SW55Ti rotor at 200 000 g for 16 h at 4
Analysis of cellular localization and phosphorylation of different
• C. Fractions (400 µl) were collected from the top of the gradient and 40 µl aliquots were analysed by Western blotting. Alternatively, for comparison of non-stimulated and stimulated cells, starting from 1 × 10 8 cells, the fractions containing the raft-marker Lyn were pooled and concentrated prior to analysis by Western blotting. For detection of PLCγ 2, the anti-PLCγ 2 antibody (1:4000; Santa Cruz Biotechnology) was used, whereas chicken Lyn present in DT40 cells was visualized using anti-chicken Lyn antibodies (1:2000; a gift from T. Kurosaki, Department of Molecular Genetics, Institute for Liver Research, Kansai Medical University, Japan). After incubation with the secondary antibody (donkey anti-rabbit antibody, dilution 1:4000; Amersham Pharmacia Biotech), the visualization was performed using the enhanced chemiluminescence (ECL ® ) system (Amersham Pharmacia Biotech).
Analysis of PLCγ 2 tyrosine phosphorylation was performed essentially as previously described [18, 24] . Typically, a sample of 6 × 10 6 cells from various DT40 cell lines was stimulated with 2 mM H 2 O 2 at 37
• C for 4-5 min or with 10 µg/ml M4 antibody for 1-3 min. The cell pellet was resuspended in 200 µl of lysis buffer [1 % (v/v) Triton, 150 mM NaCl, 10 mM Tris, pH 7.4, 1 mM EDTA, 1 mM EGTA, 0.2 mM Na 3 VO 4 , 0.5% (v/v) Nonidet P40, protease inhibitor cocktail (Roche), and phosphatase inhibitor cocktail (Sigma)] and the cells were lysed by incubation for 30 min at 4
• C. The supernatant was removed and added to anti-PLCγ 2 antibody-Protein G complexes and incubated at 4
• C for 1.5 h. After the incubation, immunocomplexes were washed with lysis buffer, resuspended in SDS gel-loading buffer and subjected to SDS/PAGE (7.5 % polyacrylamide gels) and then Western blotting. For the detection of PLCγ 2, the anti-PLCγ 2 antibody was used as described above. The detection of PLCγ 2 phosphorylation was performed using antiphosphotyrosine antibody (1:1000; Transduction Laboratories) and the secondary antibody (goat anti-mouse Ig-horseradishperoxidase-linked whole antibody from Amersham Pharmacia Biotech; diluted 1:3000). The visualization was performed by enhanced chemiluminescence and the intensity of selected areas assessed using NIH Image 1.62 program.
RESULTS
Constitutive membrane targeting of PLCγ 2 in DT40 cells
Following stimulation in a number of cellular systems, PLCγ 1 and PLCγ 2 translocate to the plasma membrane. In analysis of function and regulation of proteins that interact with the plasma membrane, specific targeting signals, such as the Cterminal sequence of H-and K-Ras (including the CAAX box) and the N-terminal sequences of Src kinases, have been used to achieve constitutive targeting [36, 37] . Among PI-PLCs, only the PLCδ1 PH domain provides a membrane anchor in the absence of stimulation by binding to PtdIns(4,5)P 2 [38, 39] . To constitutively target PLCγ 2 to the plasma membrane of DT40 cells, we have chosen to replace the PH domain of PLCγ 2 with the PLCδ1 PH domain that would localize PLCγ 2 to the plasma membrane sites where PtdIns(4,5)P 2 substrate is present. We have also chosen the N-terminus of the Src family kinases, known to determine targeting to raft microdomains, as a targeting signal for PLCγ 2. In DT40 B-cells, Lyn kinase has been described as constitutively present in the membrane rafts. Within the sequence M 1 GCIKSKGKD 10 of Lyn, two residues (Gly 2 and Cys 3 ) are likely to undergo lipid modifications, myristoylation and palmitoylation [36] . The constructs of PLCγ 2 containing either PLCδ1 PH domain (PHδ1PLCγ 2) or the N-terminal tag of Lyn (Lyn-PLCγ 2) were made ( Figure 1A ).
The stable cell lines expressing the membrane-targeted constructs of PLCγ 2 were first made in PLCγ 2-deficient cells ( Table 1 ) to confirm that the constructs were localized to the plasma membrane and that the changes have not resulted in chimeras/tagged proteins that are no longer functional in B-cell signalling. In B-cells, translocation of PLCγ 2 requires BLNK, and BLNK-deficient DT40 cells do not support translocation of PLCγ 2 [20] . Therefore, the PLCγ 2 constructs were also introduced into BLNK-deficient DT40 cells (Table 1) to test their ability to bypass the function of BLNK. As shown in Figure 1(B) , the stable cell lines of the targeted constructs (PHδ1PLCγ 2 and Lyn-PLCγ 2, middle and right panels), unlike the cells containing the wild-type construct of PLCγ 2 (PLCγ 2, left panel), demonstrated the presence of PLCγ 2 in the plasma membrane. Essentially the same results were obtained when the constructs were introduced into PLCγ 2-deficient and BLNK-deficient cells, since endogenous PLCγ 2 in BLNK-deficient cells only contributed to the staining in the cytoplasm.
Since the stimulation of B-and T-cells results in enrichment of the wild-type PLCγ in specialized plasma membrane microdomains ( [9, 13] and Figure 1 ), a further analysis of different DT40 cell lines was performed. To define membrane microdomains where PLCγ 2-targeted constructs are present, a separation method designed to isolate membrane rafts was performed ( Figure 1C) . Comparison was made between stable cell lines (made using PLCγ 2-deficient background) expressing the wildtype PLCγ 2, the PHδ1PLCγ 2 chimera or Lyn-PLCγ 2. As shown in Figure 1(C) , the wild-type PLCγ 2 and PHδ1PLCγ 2 chimera (upper panels) were not present in fractions containing lipid rafts (fractions 2-5), whereas Lyn-PLCγ 2 and endogenously present Lyn kinase (lower panels) were clearly present in the membrane raft fractions. Thus, although two targeted constructs of PLCγ 2 were present in the plasma membrane, only the Lyn-tagged PLCγ 2 construct resulted in the enrichment of PLCγ 2 in the raft microdomains in the absence of stimulation. Interestingly, the PHδ1PLCγ 2 chimera was found in lipid rafts only after stimulation in PLCγ 2-deficient cells, but not in BLNK-deficient cells ( Figure 1E ).
Effects of membrane targeting of PLCγ 2 on DT40 responses to BCR cross-linking and H 2 O 2 stress
Following the BCR stimulation or H 2 O 2 stress, phosphorylation of the wild-type PLCγ 2 can be readily detected ( Figure 1D , right panel) and is accompanied by an increase in PLC activity (Figure 2) . The constitutive membrane targeting of PLCγ 2, particularly to the rafts where many tyrosine kinases are present, could lead to constitutive phosphorylation and activation PLCγ 2.
Analysis of Lyn-targeted PLCγ 2, however, demonstrated that it did not contain phosphotyrosine in unstimulated cells ( Figure 3B) . Stimulation of the stable cell line expressing Lyn-PLCγ 2 resulted in phosphorylation of its tyrosine residues, as has been observed for the wild-type PLCγ 2 ( Figure 3B) . Similarly, the appearance of membrane patches, visualized by anti-PLCγ 2 antibody, could be detected only after stimulation ( Figure 3A) . Essentially the same results were obtained when Lyn-PLCγ 2 was introduced to BLNK-deficient ( Figure 3A) and PLCγ 2-deficient cells (results not shown). As previously reported [19] [20] [21] , in the control cell line where the wild-type PLCγ 2 was introduced into BLNKdeficient cells, translocation could not be detected ( Figure 3A , bottom panel), whereas the phosphorylation was greatly reduced (in response to H 2 O 2 , Figure 3B , right panel) or absent (in response to BCR stimulation, results not shown).
To assess activation of PLCγ 2, the formation of Ins(1,4,5)P 3 was measured in different stable DT40 cell lines after stimulation by BCR cross-linking (using M4 antibody) or stress responses to H 2 O 2 . Under the conditions used in the present study, the maximum Ins(1,4,5)P 3 production was at about 1 min after addition of M4 and about 5-10 min after addition of H 2 O 2 . These time points were used to compare different stable cell lines and demonstrated that the relative responses to M4 and H 2 O 2 for a given cell line were similar. The Ins(1,4,5)P 3 responses of different cell lines are shown in Figure 2 , using H 2 O 2 as a stimulus. Analysis of Ins(1,4,5)P 3 production by PHδ1PLCγ 2 chimera and Lyn-PLCγ 2 in a PLCγ 2-deficient background demonstrated that both constructs were functional and could restore the Ins(1,4,5)P 3 generation lacking in PLCγ 2-deficient DT40 cells. However, only Lyn-PLCγ 2 was able to restore Ins(1,4,5)P 3 production in DT40 cells deficient in BLNK; the levels of Ins(1,4,5)P 3 produced were similar to those in the stable cell line where human BLNK have been introduced into a BLNK-deficient background. These experiments suggested that the PHδ1PLCγ 2 chimera had properties of the wild-type protein both in raft-localization after stimulation and the ability to restore Ins(1,4,5)P 3 production only in PLCγ 2-deficient background (Figure 1 and 2) . In contrast, Lyntagged PLCγ 2 can bypass requirements for BLNK by providing more specific membrane-targeting signal resulting in localization of PLCγ 2 to membrane rafts.
Since the analysis of Lyn-PLCγ 2 have not revealed clear differences in BLNK − and PLCγ 2-deficient cells, further characterization is shown for the BLNK − /Lyn-PLCγ 2 cell line in comparison with a control cell line, the wild-type PLCγ 2 in PLCγ 2-deficient cells (Figure 3) . The time course for production of Ins(1,4,5)P 3 is shown in Figure 3 (C). The responses to H 2 O 2 were similar with some reduction in Ins(1,4,5)P 3 generation (about 20-25 %) observed for BLNK − /Lyn-PLCγ 2 cell line at earlier time points ( Figure 3C, left panel) . Transient responses to M4 for the two cell lines were also similar, and again only a small reduction at earlier time points was observed ( Figure 3C , right panel). The differences in Ins(1,4,5)P 3 production between the cell lines were reflected in Ca 2+ responses ( Figure 3D ).
Importance of the SH2 domains and tyrosine residues implicated in phosphorylation for the activation of raft-targeted PLCγ 2
Since the Lyn-targeted PLCγ 2 is not constitutively active and bypasses targeting to the membrane alone, it provides a system to test the requirement of the SH2 domains and tyrosine residues (implicated in phosphorylation by Btk) that are specifically related to changes leading to a high rate of PtdIns(4,5)P 2 hydrolysis. Therefore, for this analysis, mutations in both SH2 domains or mutations of Tyr 753 and Tyr 759 have been made in the context of Lyn-tagged PLCγ 2 ( Figure 4A ) and the stable cell lines generated (Table 1) . Both constructs (Lyn-PLCγ 2 R564A/R672A and Lyn-PLCγ 2 Y753F/Y759F ) were expressed at similar levels as Lyn-PLCγ 2 and were targeted to the membrane ( Figure 4B ). As shown in Figure 4 (C), phosphorylation of both constructs could be detected; the phosphorylation levels were reduced for Lyn-PLCγ 2 Y753/759F , but not as severely as in the context of nontargeted PLCγ 2 as shown previously [24] . It is possible that by introducing the Lyn-tag, the amount of PLCγ 2 and/or time that PLCγ 2 is exposed to raft-associated kinases may be increased, resulting in further phosphorylation of tyrosine residues other than Tyr 753 and Tyr 759 , known to be accessible to phosphorylation, at least in vitro [24, 25] .
Several previous studies of non-targeted PLCγ 2 in DT40 cells have demonstrated that both the SH2 domain mutation (R564A/R672A) and Y753F/Y759F mutation have diminished or greatly reduced the ability of PLCγ 2 to restore responses in PLCγ 2-deficient cells without non-specifically affecting catalytic properties in vitro [19, 24, 25] . Analysis of Ins (1,4,5) were greatly reduced. Nevertheless, similar to the control cells and Lyn-PLCγ 2 (see Figures 3 and 6) , the responses to H 2 O 2 were sustained and those following addition of M4 antibodies were only transient. In the stable cell line expressing Lyn-PLCγ 2 R564A/R672A , the amounts of Ins(1,4,5)P 3 produced at the late time points The comparison of the ratios of intensities obtained with the two antibodies resulted in an estimate that Lyn-PLCγ 2 was phosphorylated about two-fold more than PLCγ 2. Phosphorylation of Lyn-PLCγ 2 R564A/R674A was similar to Lyn-PLCγ 2, whereas Lyn-PLCγ 2 Y753F/Y759F was reduced to about 30 % of Lyn-PLCγ 2 R564A/R674A . The fold reduction after M4 stimulation for Lyn-PLCγ 2 R564A/R672A and Lyn-PLCγ 2 Y753F/Y759F constructs was as described for the wild-type PLCγ 2 in Figure 1(D) .
following H 2 O 2 stimulation were reduced; instead of sustained production of Ins(1,4,5)P 3 , the response was transient and completely diminished after 10 min ( Figure 5B, left panel) .
The results described above suggest that within the membrane-raft-targeted construct of PLCγ 2, the stimulation of PtdIns(4,5)P 2 hydrolysis requires the presence and, presumably, phosphorylation of Tyr 753 and Tyr 759 . In contrast, the SH2 domains appear to have a less critical role, but could be important for sustained activation of PLCγ 2.
Involvement of Btk, Syk and PI3K in activation of the raft-targeted PLCγ 2
In DT40 cells deficient in Btk or Syk tyrosine kinase, the BCR stimulation or H 2 O 2 treatment resulted in reduced or diminished production of Ins(1,4,5)P 3 and Ca 2+ responses [31, 32, 40, 41] . It is possible that these kinases could contribute to both translocation and activation of PLCγ 2. To test the involvement of Syk and Btk in the activation of PLCγ 2 further, Lyn-PLCγ 2 construct was introduced in Btk-or Syk-deficient cells (Table 1) . As expected, the Lyn-PLCγ 2 was present in the plasma membrane of generated stable cell lines ( Figure 6A) .
Analysis of Ins(1,4,5)P 3 production in Syk − /Lyn-PLCγ 2 and Btk − /Lyn-PLCγ 2 cell lines demonstrated some response to H 2 O 2 and M4 stimulation ( Figure 6C) , which, in agreement with previous observations [31, 32, 40, 41] , could not be detected in Syk-or Btk-deficient cells (results not shown) and were mediated by endogeous non-tagged PLCγ 2. However, as shown in Figure 6 (C), these responses were different from those in the control cell line (PLCγ 2 − /PLCγ 2). Stimulation by H 2 O 2 resulted in delayed and somewhat reduced Ins(1,4,5)P 3 production ( Figure 6C , left panel). Under these conditions Lyn-PLCγ 2 was phosphorylated ( Figure 6B ), most likely by tyrosine kinases present in the rafts and due to the inhibition of protein phosphotyrosine phosphatases by H 2 O 2 . However, when stimulation through BCR cross-linking was analysed, the phosphorylation of Lyn-PLCγ 2 was hardly detectable and this construct was very poor in restoring cellular responses ( Figures 6B and 6C ). The production of Ins(1,4,5)P 3 in both cell lines, Syk − /Lyn-PLCγ 2 and Btk − /Lyn-PLCγ 2, was greatly reduced and transient ( Figure 6C, right panel) . These results demonstrated that both Syk and Btk tyrosine kinases are required for activation of PLCγ 2 under these more physiological conditions, and further supported previous findings that their activation in BCR signalling directly or indirectly results in PLCγ 2 phosphorylation.
Analysis of DT40 cells deficient in PI3K suggested an involvement of this enzyme in stimulation of PLCγ 2 activity [42] . Previous experiments have also suggested that the PI3K product, PtdIns(3,4,5) P 3 , could have several links with PLCγ 2, the most important being the involvement in translocation/stimulation of Btk [43] . Therefore, it would be expected that the inhibition of PI3K by LY294002 or wortmannin have a similar effect as Btk deficiency. The roles of Btk and PI3K, however, seem to be somewhat different in signalling through the BCR compared with H 2 O 2 -induced stress. It has been reported that inhibition of PI3K by wortmannin completely abolished Ca 2+ mobilization in the wild-type DT40 cells stimulated by the BCR cross-linking and only reduced (up to 50 %) the Ca 2+ responses to H 2 O 2 stress; also, only in response to H 2 O 2 could the inhibition be overcome by Btk over-expression [30] . As shown in Figure 7 (B), the analysis of PLCγ 2 − /PLCγ 2 control cells is in agreement with the previous observation using the wild-type DT40 cells [30] , and demonstrated the reduction (20-25 %) of Ins(1,4,5)P 3 production by H 2 O 2 ( Figure 7B , left panel) and complete inhibition of responses to M4 ( Figure 7B , right panel) in the presence of either LY294002 or wortmannin. The same differences were observed using BLNK − /Lyn-PLCγ 2 cells ( Figure 7C ) demonstrating that effects of PI3K inhibitors do not require the presence of BLNK and that involvement of PI3K in BCR signalling may be related to activation rather than translocation of PLCγ 2, since it cannot be bypassed by Lyn targeting.
DISCUSSION
In the present study, we have described the analysis of regulation of PLCγ 2 in B-cell signalling by generating a number of DT40 Bcell lines which expressed various PLCγ 2 constructs, membranetargeted and lacking specific functional domains or residues, in a DT40 cell background deficient in different signalling components. The results support a two-step model: the membrane targeting, specifically to the lipid rafts, and subsequent activation of the enzyme. These steps require interaction with different signalling components and involve different regions of PLCγ 2. The importance of the lipid rafts in PLCγ signalling has been addressed in this and several previous studies [12] [13] [14] [15] 35, 44] . In response to different extracellular signals (e.g. stimulation of EGF receptor, collagen receptor glycoprotein VI, TCR and BCR), at least a fraction of PLCγ translocates to the lipid rafts [12] [13] [14] [15] . In DT40 B-cells, a small but significant portion of PLCγ 2 is translocated to this structure; this has also been observed for some other components including BLNK, Btk and more recently, Cbl-b [35, 44] . Our studies in DT40 cells provide evidence that the PLCγ 2 targeting to the lipid rafts is essential for signalling by this isoform. Unlike targeting mediated through the PtdIns(4,5)P 2 binding by the PLCδ1 PH domain chimera that results in general membrane targeting without enrichment in rafts, the PLCγ 2-containing Lyn-targeting sequences was specifically present in these structures and, more importantly, capable of restoring signalling in BLNK-deficient cells (Figures 1 and 2) . Although some results suggest that the substrate for PI-PLC, PtdIns(4,5)P 2 , is more abundant in rafts [45] , at least in B-cells this is not sufficient for the specific targeting. Furthermore, recent studies in cells using the PLCδ1PH domain as a probe, suggest a similar density of PtdIns(4,5)P 2 in the raft (caveolein)-containing and other areas of the plasma membrane [46] . Targeting to the rafts therefore may not be related to the substrate access by PLCγ 2, but to proximity to molecules such as Syk and Btk tyrosine kinases, known to be recruited to the rafts [14, 47] and required for PLCγ 2 signalling in B-cells [31, 32, 40, 41] . Interestingly, the Lyn-tagged PLCγ 2 was not constitutively phosphorylated and activated (Figures 2 and 3B) .
Consistent with the results from the present study (Figures 1  and 2 ), previous experiments using a different membranetargeting PLCγ 2-chimera (not fully active, most likely due to intramolecular constrains and folding problems of the construct) have shown a potential of this targeted molecule to partially restore at least some functions of BLNK [19, 20] . Although not analysed directly, these studies have also indicated the importance of specific targeting. More recent work in T-cells using targeted construct of PLCγ 1 containing the N-terminus of Src kinase Fyn, similar to the Lyn-PLCγ 2 construct described in the present study, have demonstrated the presence of this construct in the lipid rafts [34] . Furthermore, Fyn-PLCγ 1 could function without interacting with the adapter Lat and also in cells deficient in another adapter protein, Slp-76. However, in contrast to observations in B-cells, Fyn-PLCγ 1 was constitutively phosphorylated and implicated in constitutive Ca 2+ -dependent increase of transcription [34] . This difference could reflect different tyrosine kinases involved in phosphorylation of two 4) and Syk − /Lyn-PLCγ 2 (lanes 5 and 6) DT40 cell lines was performed before (−) and after (+) H 2 O 2 stimulation. After immunoprecipitation of PLCγ 2, Western blotting was performed using anti-phosphotyrosine (α-PY; upper panels) and anti-PLCγ 2 (lower panels) antibody. It was estimated that the phosphorylation of Lyn-PLCγ 2 in Btk-and Syk-deficient cells was reduced 50-60 % compared with PLCγ 2-deficient background. The M4 stimulation (lanes 7-9) was performed in a separate experiment with the control cell line having the normal difference in phosphorylation between H 2 O 2 and M4, described in Figure 1 PLCγ isoforms or a more stringent regulation of PLCγ -directed tyrosine kinase activity in resting DT40 cells compared with a specific T-cell line chosen for studies of T-cell signalling. The membrane-targeted Lyn-PLCγ 2 was used to further define post-targeting events leading to PLC activation and to analyse which domains of PLCγ 2 and which signalling components are required specifically for this step. Our results demonstrated different roles for the SH2 domains and specific tyrosine residues (Tyr 753 and Tyr 759 ) in the context of Lyn-PLCγ 2 (Figures 4 and  5) . The functional SH2 domains were only required to support prolonged Ins(1,4,5)P 3 production, whereas the presence of specific tyrosine residues (Tyr 753 and Tyr 759 ) was essential to fully restore responses by Lyn-PLCγ 2 to BCR cross-linking and H 2 O 2 .
In previous attempts to study requirements for the high rate of PtdIns(4,5)P 2 hydrolysis by PLCγ 1 separately from the requirements for translocation, an in vitro system using substrate/ Triton X-100 mixed micelles has been developed [48, 49] . In this system, the difference in activity between phosphorylated and non-phosphorylated PLCγ 1 have been observed after isolation of PLCγ 1 from cells, supporting the importance of phosphorylation in stimulation of PLC activity [48] . Using a similar system, differences have been shown between non-phosphorylated and PLCγ 2 phosphorylated in vitro, rather than in cells [50] . Nevertheless, studies of different DT40 stable cell lines have shown that mutations of several tyrosine residues introduced separately and the double mutation Y753F/Y759F of PLCγ 2, reduce or abolish Ca 2+ responses to the BCR cross-linking and H 2 O 2 [24, 25] . Further experiments have also suggested that Y753F/Y759F mutation did not affect translocation [24] . Consistent with these previous findings, the results presented in the present study ( Figures 3 and 4) show that the membrane targeting can not bypass the requirement for these specific tyrosine residues. In addition, several other observations ( Figure 6 ) suggest the importance of tyrosine phosphorylation. One of the effects of Lyn-targeting of PLCγ 2 is that this construct becomes more readily phosphorylated than the wild-type PLCγ 2, in particular following H 2 O 2 stimulation that potently inhibits protein tyrosine phosphatases. This phosphorylation of Lyn-PLCγ 2 occurs even in the absence of Btk and Syk, presumably by some other kinases present in rafts, and is accompanied by activation of Lyn-PLCγ 2.
Previous studies of the PLCγ 1 SH2 domains have suggested that these domains could be involved not only in translocation, but also in PLC activation [1] [2] [3] . For example, binding of tyrosinephosphorylated peptides, corresponding to the PLCγ 1-binding sites in the EGF receptor, induced conformational changes of recombinant PLCγ 1 and resulted in an increase of PLC activity in vitro [49] . Since the suggested binding partner for the PLCγ 2 SH2 domains is the adapter protein BLNK, the PLCγ 2-BLNK interactions could have a similar effect. Our results using Lyntargeted PLCγ 2 ( Figures 2, 3 and 5) , however, do not support this possibility and show that neither the SH2 domain mutations nor BLNK deficiency have a significant effect on Lyn-PLCγ 2 signalling following the BCR cross-linking. Furthermore, in response to H 2 O 2 stress, the effects of the SH2 mutations and BLNK deficiency are quite different; only in the case of SH2 domain mutations were the prolonged responses to H 2 O 2 affected. Similar observations in Syk-deficient and Btk-deficient cells ( Figure 6 ) do not favour Syk or Btk (the latter previously implicated in sustained substrate hydrolysis) as components responsible for the SH2 domain-mediated effects on prolonged activation. When considering allosteric regulation through the SH2 domain binding, there is also a possibility that the interactions may occur intramolecularly between phosphorylated tyrosines in PLCγ 2 (Tyr 753 , Tyr 759 or others) and one of its SH2 domains. Regardless of the identity of phosphotyrosine residues that bind the SH2 domains, this interaction could stabilize an activated form of PLCγ 2 (which could be caused by phosphorylation of critical tyrosine residues) and/or protect the phosphorylated tyrosines from the action of phosphatases, thus underlying the observed requirement in prolonged activation.
Analysis of DT40 cells revealed a number of components that contribute to PLCγ 2 signalling in this system, including Syk, Btk and PI3K; the requirements for Btk and PI3K are less stringent under some conditions [30] [31] [32] [40] [41] [42] 51] . Further studies in this and other systems suggested that the requirements for these components in PLCγ 2 signalling could reflect their involvement at several steps leading to PLC responses and could also include both indirect effects and direct interactions with PLCγ 2. For example, Syk kinase is not only required for phosphorylation of BLNK [20, 21, 24] , but also contributes to activation of Btk and PI3K [52, 53] . In the case of Btk, in addition to the suggested role in direct phosphorylation of several tyrosine residues in PLCγ 2 [24, 25] , this protein may be an important structural component of a scaffold required for the assembly of BCR signalling complexes [54] . The requirement for PI3K in PLCγ 2 signalling in B-cells could be due to its involvement in the regulation of Btk [43] . However, the link between PI3K and PLCγ isoforms could be more direct and affect either translocation or PLC activation [5] [6] [7] . Our results (Figures 6 and 7) show that Syk and Btk proteins and PI3K activity are all required for the activation step of the raft targeted PLCγ 2 in response to BCR cross-linking. Interestingly, stimulation by H 2 O 2 , accompanied by enhanced phosphorylation of the Lyn-PLCγ 2, can partially restore responses in Btk-and Syk-deficient cells by this targeted construct, suggesting that their effects at the activation step are at least in part related to phosphorylation of PLCγ 2. In contrast with our present study, the analysis of Fyn-PLCγ 1 in T-cell signalling have not supported the role of the Syk family kinase Zap-70 (zeta-associated protein 70) or the production of PtdIns(3,4,5)P 3 in the regulation of PLC activity of this construct [34] . However, it is not clear whether these differences reflect selected cell types, where the lipid-raft targeting is coupled or uncoupled with constitutive phosphorylation and activation, or physiological differences between regulation of PLCγ 1 activity in T-cells and regulation of PLCγ 2 in B-cells.
The results described in the present study, together with previous observations [14, 19, 20] , support the important role of the lipid-raft targeting as a first step in regulation of PLCγ 2. They also suggest that post-targeting events, resulting in fully active PLC, involve additional modifications and interactions that in the BCR signalling require specific tyrosine residues that are implicated in the phosphorylation of PLCγ 2 and the activation of Syk, Btk and PI3K.
